Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Express Scripts
US Army
Daiichi Sankyo
Citi
Cipla
Dow
Chubb
Moodys
Boehringer Ingelheim

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050755

« Back to Dashboard

NDA 050755 describes AUGMENTIN ES-600, which is a drug marketed by Dr Reddys Labs Inc and is included in one NDA. It is available from four suppliers. Additional details are available on the AUGMENTIN ES-600 profile page.

The generic ingredient in AUGMENTIN ES-600 is amoxicillin; clavulanate potassium. There are forty-four drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
Summary for 050755
Tradename:AUGMENTIN ES-600
Applicant:Dr Reddys Labs Inc
Ingredient:amoxicillin; clavulanate potassium
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 050755
Ingredient-typePenicillins
Mechanism of Actionbeta Lactamase Inhibitors
Suppliers and Packaging for NDA: 050755
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AUGMENTIN ES-600 amoxicillin; clavulanate potassium FOR SUSPENSION;ORAL 050755 NDA Aidarex Pharmaceuticals LLC 33261-600 33261-600-01 75 mL in 1 BOTTLE, PLASTIC (33261-600-01)
AUGMENTIN ES-600 amoxicillin; clavulanate potassium FOR SUSPENSION;ORAL 050755 NDA Aidarex Pharmaceuticals LLC 33261-970 33261-970-01 200 mL in 1 BOTTLE, PLASTIC (33261-970-01)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:FOR SUSPENSION;ORALStrength600MG/5ML;EQ 42.9MG BASE/5ML
Approval Date:Jun 22, 2001TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
McKinsey
Moodys
McKesson
Johnson and Johnson
Chinese Patent Office
AstraZeneca
Federal Trade Commission
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot